Routine evaluation of MRE and MRI in Crohn's Disease could be a way to detect axSpa. 25% of 48 CD patients had abnormal SI joint finding, majority asymptomatic, female, and had stricturing or penetrating CD @RheumNow #ACR21 Abst#1306 #ACRBest https://t.co/MYMV3UDGck https://t.co/p9fov02OdH

• Clinical and Imaging Characteristics of Spondyloarthritis Among Crohn’s Disease…

What matters for PsA pts & MDs? In this study, pts and MDs in consensus w/#arthritis dse activity, fatigue & pain as impt aspects of PsA care; but disparities still exist👇 MDs-clinical Pts-access to care, sleep Communication is🔑➡shared decision making @RheumNow #ACR21 abs1165 https://t.co/Zd4r47OMGx

A clever hack for those who have difficulty with public speaking! I would add breathe to this list! Janet Zeide presents "RHEUM" during The Gift of Gab at #ACR21 @RheumNow https://t.co/fjAFZDiao5

A retrospective cohort study demonstrates a statistically and clinically significant lower risk for developing PsA among patients with psoriasis that receive biologic medications Abst #1355 #ACR21 @RheumNow https://t.co/OK20VKO82f

@SattuiSEMD on frailty in PMR. High prevalence frailty (12-17%) and pre-frailty (54-59%). Frailty associated worse HRQoL. Abstr#1392 #ACR21 @RheumNow https://t.co/Y2evVHrrTa

#ACR21 Opening Day Recap: Drs. Cush, Dao ( @KDAO2011) , Tate ( @uptotate) and Reyes ( @RHEUMarampa ) https://t.co/v0DH4jY84v https://t.co/oflVOkzSie

• https://bit.ly/3BNNauI

"If you follow this advice👇, you will be the best speaker in the RHEUM!" 😉😊🤓 @RheumNow #ACR21 https://t.co/y2IYMFJChE

Efficacy to the COVID-19 vaccine is based on both humoral (antibody) and cellular responses. Rituximab impairs B-cell response but not T-cell response to COVID-19 vaccine in auto-immune diseases @RheumNow #ACR21 8M101 Mariette X https://t.co/RoFTC6VpCt

Prevalence of abnormal SI joint findings on MRE and MRI is 25% in Crohn's pts. Majority didn't report back pain, were female, and had intestinal complications of CD. Abs 1306 #ACR21 #RheumNow @RheumNow https://t.co/LOGoxAfrQi https://t.co/qAKC8GCLno

• Clinical and Imaging Characteristics of Spondyloarthritis Among Crohn’s Disease…

Abst1005 #ACR21 #ACRBest @RheumNow study identifies monocyte-derived DC population characterized as CD209+/CD14+ DC in the synovium of RA and PsA patients sensitive to JAK/STAT, but not TNF inhibition.

VACOLUP study: COVID19 vacc, 1189 SLE pts 👉No sig. diff based on gender, age, nor type of vax 👉3.2% pts w/SLE flare 👉Flares mainly fatigue and MSK symptoms (SLE flare or side-effect of the vac?) https://t.co/w5dYsLkk5D #ACR21 Abst#1421 @RheumNow #ACRBest

• Efficacy and Tolerance of Vaccination Against COVID-19 in Patients with Systemi…

Dr Keen presenting on GCA admitted to hospital. Propensity score matched to non-GCA population. Increased all cause mortality compared to general population in Western Australia (aHR 1.13). Most pronounced in early years after diagnosis. Abstr#1393 #ACR21 @RheumNow https://t.co/laW8mxp6uq

Dr Björn Bühring highlights the burden of #multimorbidity and particularly #sarcopenia in older patients with #rheumatoidarthritis. #ACR21 @RheumNow https://t.co/3xGtx48DAU

Majority of rheum pts on csDMARDs, TNFi, JAKi & TCZ had adequate serologic response to m-RNA based vaccines. Poor vaccine reactivity mainly assoc'd w/ RTX, steroids, and MMF. Study did not include ABA. Abs 1087 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/q4C66Htz5a https://t.co/MS7cqdFWBi

• The Humoral Immunity of mRNA-Based SARS-CoV2 Vaccine in Autoimmune Rheumatic Di…

Abst1083 #acr21 #ACRBest @RheumNow study of COVID-19 outcomes in pts w/systemic auto inflammatory disease:31% had a flare of underlying SAID, either concurrently (20%) or after recovering from COVID-19 (11%). The majority of SAID pts w/COVID-19 reported mild to moderate illness https://t.co/qzYfmYpA25